DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Gadobenic acid
Gadobenic acid
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Imaging Diagnostics by Combining Contrast Agents
Drug-Induced Anaphylaxis in China: a 10 Year Retrospective Analysis of The
The Choice of Gadolinium-Based Contrast Agents: a Radiologist’S Responsibility Between Pharmaceutical Equivalence and Bioethical Issues
Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Table of Contents
Art. 31 Gadolinium
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Drug Consumption at Wholesale Prices in 2017 - 2020
Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO
Chapter 138A Pharmacy and Poison Regulations.Pdf
(PRAC) Der European Medicines Agency (EMA) Bezüglich Gadoliniumhaltiger MR- Kontrastmittel: Was Bedeutet Dies Für Die Radiologen in Der Schweiz?
FDA Listing of Established Pharmacologic Class Text Phrases January 2021
Stembook 2018.Pdf
WO 2012/136813 A2 11 October 2012 (11.10.2012) P O P C T
Gadolinium Containing Contrast Agents
Pharmacy and Poisons (Amendment) Bill 2014 Contents
Top View
Risk of Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents
WO 2017/222911 A1 (.Pdf)
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Gadolinium Retention After Gadolinium Based Contrast MRI in Patients with Normal Renal Function
(12) Patent Application Publication (10) Pub. No.: US 2011/0269704 A1 Seigfried (43) Pub
Marrakesh Agreement Establishing the World Trade Organization
Biem Pharmaceuticals Is
Atc Index 2010
Atc Index 2009
Gadolinium Containing Contrast Agents (Gdcas) Are Complexes of Paramagnetic Gadolinium (III) with Different Types of Organic Chelators
)&F1y3x PHARMACEUTICAL APPENDIX to THE
WO 2014/153118 Al 25 September 2014 (25.09.2014) P O P C T
Comprehensive Contrast Policy Page 2 of 25
Cancer Du Testicule
Interreader Reliability of Liver Imaging Reporting and Data System Treatment Response: a Systematic Review and Meta-Analysis
Name of the Medicinal Product
Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
Gadolinium-Based Contrast Agents and Risk Of
(12) United States Patent (10) Patent No.: US 9,526,824 B2 Ferrari Et Al
Gadolinium Contrast Agents and Risk of Tissue Accumulation Removal Of
RCR Position Statement on the Revision of Marketing Authorisations
Thrombocytopenia Induced by Iodinated Contrasts. Utility of Rare Diseases Research Gadolinium and Intravascular Ultrasound
Contribution of Italian Clinical Research for Contrast Media‑Induced Nonrenal Adverse Drug Reactions Over the Last Three Decades: a Systematic Review
Gadolinium-Containing Agents Restrictions on Use
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Danish Pharmacovigilance Update
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Medical Imaging Drugs Advisory Committee Meeting
Customs Tariff - Schedule
Assessment Report
Gadolinium-Containing Contrast Agents
(12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Gbcas: Regulatory Update & Information on Guerbet's Products
Pharmaceutical Appendix to the Tariff Schedule 2
Multihance® (Dimeglumine Gadobenate)
4,436 Reports from Italy, Accepted in the Who Upm
Medicines Adverse Reactions Committee
Application for Inclusion of Gadoterate Meglumine Pdf, 853Kb
Gadolinium-Containing Contrast Agents
Resolution Ap (2000) 1
Contrast Media Pharmacovigilance in Diagnostic Imaging: a Tool to Enhance